IBA Proton Therapy is the proton therapy division of Ion Beam Applications (IBA), a high-technology healthcare company founded in 1986 as a spin-off of UCL. It develops and supplies proton therapy systems for cancer centers and has designed and installed systems at more than 60 medical centers worldwide. The company also partners with clinical institutions and industry collaborators to advance proton therapy technology.
Best NOMOSBest NOMOS develops oncology products and solutions for medical professionals planning, targeting, and delivering radiation treatments. It is known for its IMRT and IGRT innovations and says it delivered the first commercial IMRT system, PEACOCK®, in 1992. The company serves brachytherapy and external-beam radiation therapy practices as a member of TeamBest.PITTSBURGH, PA
Aktina MedicalFamily-owned Aktina Medical grew from George Zacharopoulos’s basement-and-garage work in the 1970s into a Congers manufacturer of radiation oncology systems and a provider of medical physics consulting. Owned and operated by certified medical physicists with more than 30 years of experience, the company has worked from its current manufacturing facility since 1993 and develops equipment such as LINAC quality-assurance tools and radiosurgery components alongside clinical physics services.CONGERS, NY
Sun NuclearFrom its Melbourne, Florida headquarters, Sun Nuclear develops quality-management solutions that help cancer centers check diagnostic imaging and radiation-therapy systems. Now part of Mirion Medical, the company combines software such as its SunCHECK connected workspace with measurement devices and phantoms, supporting independent QA at more than 6,000 cancer-treatment facilities in 130-plus countries. Its global support operation includes more than 20 medical physicists, backed by a 5,000-square-foot training center built to resemble a clinical setting.BALTIMORE, MD
Xcision Medical Systems, LLCColumbia-based Xcision Medical Systems develops stereotactic radiotherapy technology focused specifically on breast cancer, led by its GammaPod system for early-stage disease. Developed from a patent licensed from the University of Maryland School of Medicine, GammaPod uses focused, noninvasive radiation and is designed to shorten treatment to as few as five days. The system has received FDA 510(k) clearance and carries the CE Mark in Europe.COLUMBIA, MD